Yervoy (Ipilimumab) injection |
Yervoy (Ipilimumab) injection Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Xelstrym (dextroamphetamine) transdermal system |
Xelstrym (dextroamphetamine) transdermal system Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Xeglyze (abametapir) |
Xeglyze (abametapir) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Xaciato (clindamycin phosphate) vaginal gel |
Xaciato (clindamycin phosphate) vaginal gel Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Vyvanse (lisdexamfetamine dimesylate) capsule and chewable tablet |
Vyvanse (lisdexamfetamine dimesylate) capsule and chewable tablet Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Veklury (remdesivir) |
Veklury (remdesivir) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Tybost (cobicistat) |
Tybost (cobicistat) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Selenious acid injection (selenious acid) intravenous solution |
Selenious acid injection (selenious acid) intravenous solution Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Zinc sulfate injection intravenous solution |
Zinc sulfate injection intravenous solution Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Tralement (trace elements injection 4) intravenous solution |
Tralement (trace elements injection 4) intravenous solution Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Multrys (trace elements injection 4) intravenous solution |
Multrys (trace elements injection 4) intravenous solution Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Tirosint-SOL (Levothyroxine sodium) oral solution |
Tirosint-SOL (Levothyroxine sodium) oral solution Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Teflaro® |
Teflaro® (ceftaroline fosamil) for injection Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Riomet ER (metformin hydrochloride for extended-release oral suspension) |
Riomet ER (metformin hydrochloride for extended-release oral suspension) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Qelbree (viloxazine extended-release capsules) |
Qelbree (viloxazine extended-release capsules) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Pradaxa (dabigatran etexilate) capsule and oral pellet |
Pradaxa (dabigatran etexilate) capsule and oral pellet Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Natroba (spinosad) topical suspension |
Natroba (spinosad) topical suspension Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Mydayis (mixed salts of a single-entity amphetamine product) extended-release capsules |
Mydayis (mixed salts of a single-entity amphetamine product)
extended-release capsules Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Mircera (methoxy polyethylene glycol-epoetin beta) injection |
Mircera (methoxy polyethylene glycol-epoetin beta) injection Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Mavyret (glecaprevir/pibrentasvir) |
Mavyret (glecaprevir/pibrentasvir) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Lumason (sulfur hexafluoride lipid-type A microspheres) |
Lumason (sulfur hexafluoride lipid-type A microspheres) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Lotemax (loteprednol etabonate ophthalmic gel) 0.5% |
Lotemax (loteprednol etabonate ophthalmic gel) 0.5% Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Lithium |
Lithium Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Ultravate (halobetasol propionate) lotion |
Ultravate (halobetasol propionate) lotion Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Lexette (halobetasol propionate) topical foam |
Lexette (halobetasol propionate) topical foam Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Kapspargo Sprinkle (metoprolol succinate) extended-release capsule |
Kapspargo Sprinkle (metoprolol succinate) extended-release capsule Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Januvia (sitagliptin) |
Januvia (sitagliptin) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Janumet (sitagliptin and metformin hydrochloride) |
Janumet (sitagliptin and metformin hydrochloride) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Janumet XR (Sitagliptin and metformin hydrochloride extended-release) |
Janumet XR (sitagliptin and metformin hydrochloride extended-release) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Gilenya (fingolimod) capsules |
Gilenya (fingolimod) capsules Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Tascenso ODT (fingolimod) orally disintegrating tablet |
Tascenso ODT (fingolimod) orally disintegrating tablet Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Gattex (teduglutide) |
Gattex (teduglutide) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Evekeo ODT (amphetamine sulfate) orally disintegrating tablets |
Evekeo ODT (amphetamine sulfate) orally disintegrating tablets Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Sonalleve MR-HIFU |
Sonalleve MR-HIFU Executive Summary |
9/26/2024 |
Cutaquig (Immune Globulin Subcutaneous (Human) - hipp) |
Cutaquig (Immune Globulin Subcutaneous (Human) - hipp) Safety and Utilization Review |
9/26/2024 |
Agriflu (Influenza Virus Vaccine) |
Agriflu (Influenza Virus Vaccine) Safety and Utilization Review |
9/26/2024 |
PulseRider Aneurysm Neck Reconstruction Device (H160002) |
PulseRider Aneurysm Neck Reconstruction Device (H160002) Executive Summary |
9/26/2024 |
Pleximmune™ (H130004) |
Pleximmune™ (H130004) Executive Summary |
9/26/2024 |
Xyntha (Antihemophilic Factor (Recombinant), Plasma/Albumin Free) |
Xyntha (Antihemophilic Factor (Recombinant), Plasma/Albumin Free) Safety and Utilization Review |
9/26/2024 |
Flourish™ Pediatric Esophageal Atresia Device (H150003) |
Flourish™ Pediatric Esophageal Atresia Device (H150003) Executive Summary |
9/26/2024 |
Enterra® Therapy System (H990014) |
Enterra® Therapy System (H990014) Executive Summary |
9/26/2024 |
Dyanavel XR (amphetamine) extended-release tablet |
Dyanavel XR (amphetamine) extended-release tablet Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Medtronic Contegra® Pulmonary Valved Conduit Models 200 (unsupported) and 200S (supported) (H020003) |
Medtronic Contegra® Pulmonary Valved Conduit Models 200 (unsupported) and 200S (supported) (H020003) Executive Summary |
9/26/2024 |
Cleocin hydrochloride (clindamycin hydrochloride) |
Cleocin hydrochloride (clindamycin hydrochloride) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Cleocin phosphate (clindamycin phosphate) |
Cleocin phosphate (clindamycin phosphate) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Cleocin phosphate in dextrose 5% in plastic container (clindamycin
phosphate) |
Cleocin phosphate in dextrose 5% in plastic container (clindamycin phosphate) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Clindamycin phosphate in 0.9% sodium chloride (clindamycin
phosphate) |
Clindamycin phosphate in 0.9% sodium chloride (clindamycin phosphate) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Cimduo (lamivudine\tenofovir disoproxil fumarate) |
Cimduo (lamivudine\tenofovir disoproxil fumarate) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Temixys (lamivudine\tenofovir disoproxil fumarate) |
Temixys (lamivudine\tenofovir disoproxil fumarate) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Chantix (varenicline tartrate) tablets |
Chantix (varenicline tartrate) tablets Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Cafcit injection (caffeine citrate injection, USP) |
Cafcit injection (caffeine citrate injection, USP) Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Azstarys (serdexmethylphenidate and dexmethylphenidate) capsules |
Azstarys (serdexmethylphenidate and dexmethylphenidate) capsules Pediatric Postmarketing Pharmacovigilance Review |
9/26/2024 |
Epicel (cultured epidermal autografts) |
Epicel (cultured epidermal autografts) Memorandum |
5/9/2024 |
Liposorber LA-15 System |
Liposorber LA-15 System Executive Summary |
5/9/2024 |
The Tether - Vertebral Body Tethering System |
The Tether - Vertebral Body Tethering System Executive Summary |
5/9/2024 |
Medtronic Activa Neurosimulator for Dystonia Treatment |
Medtronic Activa Neurosimulator for Dystonia Treatment Executive Summary |
5/9/2024 |
Minimally Invasive Deformity Correction (MID-C) System |
Minimally Invasive Deformity Correction (MID-C) System Executive Summary |
5/9/2024 |
Isentress (raltegravir potassium) |
Isentress Safety and Utilization Review |
09/12/2016 |
Lysteda (tranexamic acid) |
Lysteda Safety and Utilization Review |
09/12/2016 |
Salonpas Relief (methyl salicylate 10% and 1-menthol 3%P Patch) |
Salonpas Relief Safety and Utilization Review |
09/12/2016 |
Aleve PM® (naproxen sodium 220 mg and diphenhydramine hydrochloride 25 mg) |
Aleve PM® Safety and Utilization Review |
02/03/2017 |
Astepro (azelastine hydrochloride) |
Astepro Safety and Utilization Review |
02/03/2017 |
Jetrea® (ocriplasmin) Intravitreal Injection |
Jetrea® Safety and Utilization Review |
02/03/2017 |
Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol tablets, for oral use) |
Quartette Safety and Utilization Review |
02/03/2017 |
Spectazole (econazole nitrate) cream, 1% Ecoza (econazole nitrate) topical foam, 1% |
Spectazole/Ecoza Safety and Utilization Review |
02/03/2017 |
Truvada® (emtricitabine and tenofovir disoproxil fumarate) |
Truvada® Safety and Utilization Review |
02/03/2017 |
Xerese® (5% acyclovir and 1% hydrocortisone cream) |
Xerese® Safety and Utilization Review |
02/03/2017 |
Aloxi (palonosetron hydrochloride) |
Aloxi Safety and Utilization Review |
08/04/2017 |
Arnuity Ellipta (fluticasone furoate) |
|
08/04/2017 |
Asmanex HFA and Asmanex Twisthaler (mometasone furoate inhalation) |
Asmanex HFA and Asmanex Twisthaler Safety and Utilization Review |
08/04/2017 |
Cymbalta (duloxetine) |
Cymbalta Safety and Utilization Review |
08/04/2017 |
Emsam (selegiline transdermal system) |
Emsam Safety and Utilization Review |
08/04/2017 |
GRASTEK® (Timothy Grass Pollen Allergen Extract) Tablet for Sublingual Use |
GRASTEK Safety and Utilization ReviewFDA Drug Utilization Information on GRASTEK and ORALAIR |
08/04/2017 |
Latisse® (bimatoprost ophthalmic solution) 0.03% |
Latisse® Safety and Utilization Review |
08/04/2017 |
Namenda and Namenda XR extended-release (memantine hydrochloride) |
Namenda and Namenda XR Safety and Utilization Review |
08/04/2017 |
ORALAIR (Sweet Vernal, Orchard Perennial rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) Tablet for sublingual Use |
ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy, and
Kentucky Blue Grass Mixed Pollens Allergen Extract)
Tablet for Sublingual Use MemorandumK and ORALAIR |
08/04/2017 |
Priftin® (rifapentine) |
Priftin® Safety and Utilization Review |
08/04/2017 |
Reyataz® (atazanavir) |
Reyataz® Safety and Utilization Review |
08/04/2017 |
Taclonex (betamethasone dipropionate/calcipotriene hydrate) 0.064%/0.005% |
Taclonex Safety and Utilization Review |
08/04/2017 |
Zetonna (ciclesonide) |
Zetonna (ciclesonide) Safety and Utilization Review |
08/04/2017 |
Dymista (azelastine hydrochloride fluticasone propionate) |
Dymista (azelastine hydrochloride fluticasone propionate) Pediatric Safety Review |
01/07/2018 |
Edurant (rilpivirine) Complera and Odefsey |
Edurant (rilpivirine) Complera and Odefsey Pediatric Safety Review |
01/07/2018 |
Merrem IV (meropenem) |
Merrem IV (meropenem) Pediatric Safety Review |
01/07/2018 |
Naftin (nafifine hydrochloride) |
Naftin (nafifine hydrochloride) Pediatric Safety and Drug Utilization Review |
01/07/2018 |
OTIPRO (ciprofloxacin otic suspension) |
OTIPRO (ciprofloxacin otic suspension) Pediatric Safety Review |
01/07/2018 |
PAZEO (olopatadine hydrochloride ophthalmic solution) |
PAZEO (olopatadine hydrochloride ophthalmic solution) Pediatric Safety Review |
01/07/2018 |
QNASL beclomethasone dipropionate) nasal aerosol |
QNASL beclomethasone dipropionate) nasal aerosol Safety Review |
01/07/2018 |
Treximet (naproxen sodium sumatriptan succinate) |
Treximet (naproxen sodium sumatriptan succinate) Safety Review |
01/07/2018 |
Valcyte (valganciclovir) |
Valcyte (valganciclovir) Safety Review |
01/07/2018 |
Atropine Sulfate Ophthalmic Solution, USP 1% |
Atropine Sulfate Ophthalmic Solution, USP 1% Pediatric Postmarketing Pharmacovigilance Review |
03/05/2018 |
Emend (aprepitant) Capsule and Oral Suspension |
Emend (aprepitant) Capsule and Oral Suspension Pediatric Safety Review |
03/05/2018 |
Epicel (cultured epidermal autografts) |
Epicel (cultured epidermal autografts) Executive Summary, Pediatric Safety Update |
03/05/2018 |
Epiduo Forte (adapalene/benzoyl peroxide, 0.3%/2.5%) gel |
Epiduo Forte (adapalene/benzoyl peroxide, 0.3%/2.5%) gel Pediatric Safety Review |
03/05/2018 |
Flourish Pediatric Esophageal Atresia Device |
Flourish 2018 Executive Summary |
03/05/2018 |
Gadavist (gadobutrol), Eovist or Primovist (gadoxetate disodium) |
Gadavist (gadobutrol) Eovist or Primovist (gadoxetate disodium) Pediatric Safety Review |
03/05/2018 |
Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) |
Gardasil 9 Pediatric Safety and Utilization Review |
03/05/2018 |
Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) oral tablets |
Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) oral tablets Pediatric Safety Review |
03/05/2018 |
Kapvay (clonidine extended-release) tablets |
Kapvay® (clonidine extended-release) tablets Pediatric Safety and Drug Utilization Review |
03/05/2018 |
Nucala (mepolizumab) |
Nucala (mepolizumab) Pediatric Safety Review |
03/05/2018 |
Saphris (asenapine) |
Saphris (asenapine) Pediatric Safety Review |
03/05/2018 |
Tivicay (dolutegravir) |
Tivicay (dolutegravir) Pediatric Safety Review |
03/05/2018 |
Trumenba Meningococcal Group B Vaccine |
Trumenba Pediatric Pediatric Safety Review |
03/05/2018 |
Banzel (rufinamide) |
Banzel (rufinamide) Pediatric Safety Review Banzel (rufinamide) Pediatric Utilization Review |
04/25/2018 |
Liposorber LA-15 System |
Liposorber LA-15 System 2018 Executive Summary |
04/25/2018 |
Medtronic Activa Dystonia Therapy |
Medtronic Activa Dystonia Therapy 2018 Executive Summary |
04/25/2018 |
Adzenys XR and Dyanavel XR (amphetamine) |
Dyanavel Pediatric Safety Review |
06/13/2018 |
Anthim (obiltoxaximab) |
Anthim Pediatric Safety Review |
06/13/2018 |
Aptensio XR and Quillichew (methylphenidate hydrochloride) |
Aptensio XR and Quillichew ER Pediatric Safety Review |
06/13/2018 |
Cinqair (reslizumab) |
Cinqair Pediatric Safety Review |
06/13/2018 |
Cutivate (fluticasone propionate) |
Cutivate Pediatric Safety Review |
06/13/2018 |
Descovy (emtricitabine and tenofovir alafenamide) |
Descovy Pediatric Safety Review |
06/13/2018 |
Epivir (lamivudine) |
Epivir Pediatric Safety Review |
06/13/2018 |
Kaletra (lopinavir and ritonavir) |
Kaletra Pediatric Safety Review |
06/13/2018 |
Natroba (spinosad) |
Natroba Pediatric Safety Review |
06/13/2018 |
Noxafil (posaconazole) |
Noxafil Pediatric Safety Review |
06/13/2018 |
Oraltag (iohexol) |
Oraltag Pediatric Safety Review |
06/13/2018 |
Otovel Otic Solution (ciprofloxacin and fluocinolone acetonide) |
Ovotel Pediatric Safety Review |
06/13/2018 |
Prilosec (omeprazole) |
Prilosec Pediatric Safety Review |
06/13/2018 |
ProAir RespiClick (abuterol sulfate) |
ProAir Respiclick Pediatric Safety Review |
06/13/2018 |
Procysbi (cysteamine bitartrate) |
Procysbi Pediatric Safety Review |
06/13/2018 |
Teflaro Injection (ceftaroline fosamil) |
Teflaro Pediatric Safety Review |
06/13/2018 |
Tetracaine Hydrochloride Ophthalmic Solution (tetracaine hydrochloride) |
Tetracaine Pediatric Safety Review |
06/13/2018 |
Xopenex HFA Inhalation Aerosol (levalbuterol) |
Xopenex Pediatric Safety Review |
06/13/2018 |
Bexsero (Meningococcal Group B Vaccine) |
Bexsero Safety Review |
09/12/2018 |
Contegra Pulmonary Valved Conduit (Humanitarian Device Exemption [HDE]) |
Contegra 2018 Executive Summary |
09/12/2018 |
Elana Surgical Kit (HDE) |
Elana Surgical Kit 2018 Executive Summary |
09/12/2018 |
Enterra Therapy System (HDE) |
Enterra 2018 Executive Summary |
09/12/2018 |
Entocort EC (budesonide) |
Entocort EC Safety Review |
09/12/2018 |
Epzicom (abacavir sulfate and lamivudine) and Ziagen (abacavir sulfate) |
Epzicom and Ziagen Safety Review |
09/12/2018 |
Kovanaze (tetracaine HCl and oxymetazoline HCl) |
Kovanaze Safety Review |
09/12/2018 |
Lamictal (lamotrigine) |
Lamictal Safety Review |
09/12/2018 |
Oraverse (phentolamine mesylate) |
Oraverse Safety Review |
09/12/2018 |
Pancreaze & Pertzye (pancrelipase) |
Pancreaze & Pertzye Safety Review |
09/12/2018 |
Pleximmune™ in-vitro diagnostic test (HDE) |
Pleximmune™2018 Executive Summary |
09/12/2018 |
PulseRider Aneurysm Neck Reconstruction Device (HDE) |
PulseRider 2018 Executive Summary |
09/12/2018 |
Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) |
Quadracel Safety Review |
09/12/2018 |
Renvela (sevelamer carbonate) |
Renvela Safety Review |
09/12/2018 |
Zomig Nasal Spray (zolmitriptan) |
Zomig Nasal Spray Safety Review |
09/12/2018 |
Aczone (dapsone) gel, 7.5% |
Aczone Safety Review |
03/28/2019 |
Adynovate |
Adynovate Safety Review |
03/28/2019 |
AirDuo RespiClick (fluticasone propionate and salmeterol xinafoate) ArmonAir RespiClick (fluticasone propionate) |
AirDuo Respiclick and ArmonAir Respiclick Safety Review |
03/28/2019 |
Avelox (moxifloxacin, tablets and injection) |
Avelox Safety Review |
03/28/2019 |
Caldolor (ibuprofen) IV injection |
Caldolor Safety Review |
03/28/2019 |
Cubicin® and Cubicin® RF (daptomycin for injection) |
Cubicin Safety Review |
03/28/2019 |
Dexilant, Dexilant SoluTab (dexlansoprazole) |
Dexilant Safety Review |
03/28/2019 |
Epicel (cultured epidermal autografts) |
Epicel 2019 Executive Summary |
03/28/2019 |
Eucrisa (crisaborole) ointment, 2% |
Eucrisa Safety Review |
03/28/2019 |
Flourish™ Pediatric Esophageal Atresia Device |
Flourish 2019 Executive Summary |
03/28/2019 |
IXINITY [Coagulation Factor IX (Recombinant)] |
IXINITY Safety Review |
03/28/2019 |
Liletta (levonorgestrel-releasing intrauterine system) |
Liletta Safety Review |
03/28/2019 |
Liposorber® LA-15 System |
Liposorber 2019 Executive Summary |
03/28/2019 |
Lyrica (pregabalin) |
Lyrica Safety Review |
03/28/2019 |
Medtronic Activa Neurostimulator for Dystonia Treatment |
Medtronic Activa 2019 Executive Summary |
03/28/2019 |
Narcan (naloxone) nasal spray |
Narcan Safety Review |
03/28/2019 |
Ofirmev (acetaminophen) injection |
Ofirmev Safety Review |
03/28/2019 |
Selzentry (maraviroc) |
Selzentry Safety Review |
03/28/2019 |
Spiriva Respimat (tiotropium bromide) |
Spiriva Safety Review |
03/28/2019 |
Symbicort (budesonide/ formoterol fumarate dihydrate) |
Symbicort Safety Review |
03/28/2019 |
Tarceva™ (erlotinib) |
Tarceva Safety Review |
03/28/2019 |
Velcade® (bortezomib) |
Velcade Safety Review |
03/28/2019 |
Ativan injection (lorazepam injection) |
Ativan Pediatric Safety Review |
09/19/2019 |
Calcium gluconate injection (calcium gluconate) |
Calcium Gluconate Pediatric Safety Review |
09/19/2019 |
Cerebyx® (fosphenytoin sodium) |
Cerebyx® Pediatric Safety Review |
09/19/2019 |
Contegra Pulmonary Valved Conduit (Humanitarian Device Exemption [HDE]) |
Contegra 2019 Executive Summary |
09/19/2019 |
Dotarem (gadoterate meglumine) |
Dotarem Pediatric Safety Review |
09/19/2019 |
E-Z-HD (barium sulfate) |
Barium Sulfate Pediatric Safety Review |
09/19/2019 |
Elana Surgical Kit (HDE) |
Elana Surgical Kit 2019 Executive Summary |
09/19/2019 |
Enterra Therapy System (HDE) |
Enterra Therapy System 2019 Executive Summary |
09/19/2019 |
Fycompa oral tablets and suspension (perampanel) |
Fycompa Pediatric Safety Review |
09/19/2019 |
Gammaplex - Immune Globulin Intravenous (Human) 5% Liquid |
Gammaplex Safety and Utilization Review |
09/19/2019 |
Harvoni (ledipasvir and sofosbuvir) |
Harvoni Pediatric Safety Review |
09/19/2019 |
Isentress and Isentress HD (raltegravir) |
Isentress and Isentress HD Pediatric Safety Review |
09/19/2019 |
Latuda (lurasidone hydrochloride) |
Latuda Pediatric Safety Review |
09/19/2019 |
Liquid E-Z-Paque (barium sulfate) |
Barium Sulfate Pediatric Safety Review |
09/19/2019 |
NUWIQ® (simoctocog alfa) |
NUWIQ® Safety and Utilization Review |
09/19/2019 |
Pleximmune™ in-vitro diagnostic test (HDE) |
Pleximmune™ 2019 Executive Summary |
09/19/2019 |
PulseRider Aneurysm Neck Reconstruction Device (HDE) |
PulseRider 2019 Executive Summary |
09/19/2019 |
Rapivab® (peramivir) |
Rapivab® Pediatric Safety Review |
09/19/2019 |
Readi-Cat 2, Readi-Cat 2 smoothies (barium sulfate) |
Barium Sulfate Pediatric Safety Review |
09/19/2019 |
Ryzodeg 70/30 (insulin degludec and insulin aspart injection) for subcutaneous use 100 units/mL (U-100) in 3mL FlexTouch Pen |
Ryzodeg Pediatric Safety Review |
09/19/2019 |
Simponi (golimumab SC), Simponi Aria (golimumab IV) |
Simponi Pediatric Safety Review |
09/19/2019 |
Sovaldi (sofosbuvir) |
Sovaldi Pediatric Safety Review |
09/19/2019 |
Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) |
Stribild Pediatric Safety Review |
09/19/2019 |
TACHOSIL (Fibrin Sealant Patch) |
TACHOSIL Safety and Utilization Review |
09/19/2019 |
Tresiba (insulin degludec injection) for subcutaneous use, 100 units/mL (U-100) in 3mL single-patient-use FlexTouch Pen; 200 units/mL (U-200) in 3mL single-patient-use FlexTouch Pen; 100 units/mL (U-100) 10 mL in multiple-dose vial |
Tresiba Pediatric Safety Review |
09/19/2019 |
Varibar pudding (barium sulfate) |
Barium Sulfate Pediatric Safety Review |
09/19/2019 |
Vigamox (moxifloxacin hydrochloride ophthalmic solution 0.5%) |
Vigamox Pediatric Safety Review |
09/19/2019 |
Visipaque injection (iodixanol) |
Visipaque Pediatric Safety Review |
09/19/2019 |
WILATE (von Willebrand Factor/ Coagulation Factor VIII Complex (Human)) |
WILATE Safety and Utilization Review |
09/19/2019 |
Zemplar (paricalcitol) |
Zemplar Pediatric Safety Review |
09/19/2019 |
Zymar® 0.3% (gatifloxacin ophthalmic solution) |
Zymar® Pediatric Safety Review |
09/19/2019 |
AFSTYLA (antihemophilic factor (recombinant), single chain) |
AFSTYLA Safety and Utilization Review |
07/13/2020 |
Butrans (buprenorphine transdermal system) |
Butrans Pediatric Safety and Utilization Review |
07/13/2020 |
DraxImage DTPA (technetium TC-99m pentetate kit) injection and inhalation |
DraxImage DTPA Pediatric Safety Review |
07/13/2020 |
Dysport (AbobotulinumtoxinA) |
Dysport Pediatric Safety Review |
07/13/2020 |
Epicel (cultured epidermal autografts) |
Epicel 2020 Executive Summary |
07/13/2020 |
KOVALTRY (antihemophilic factor (recombinant)) |
KOVALTRY Safety and Utilization Review |
07/13/2020 |
Liposorber® LA-15 System (HDE) |
Liposorber® LA-15 System 2020 Executive Summary |
07/13/2020 |
Lumason (sulfur hexafluoride lipid-type A microspheres) injectable suspension |
Lumason Pediatric Safety Review |
07/13/2020 |
Medtronic Activa® Dystonia Therapy (HDE) |
Medtronic Activa® Dystonia Therapy 2020 Executive Summary |
07/13/2020 |
Omidria (phenylephrine and ketorolac intraocular solution) |
Omidria Pediatric Safety Review |
07/13/2020 |
Stelara (ustekinumab) injection |
Stelara Pediatric Safety Review |
07/13/2020 |
Symfi Lo™ (efavirenz 400mg + lamivudine 300mg + tenofovir disoproxil fumarate 300mg) and Symfi™ (efavirenz 600mg + lamivudine 300mg + tenofovir disoproxil fumarate 300mg) |
Symfi Lo™ and Symfi™ Pediatric Safety Review |
07/13/2020 |
Canasa (mesalamine suppositories for rectal use) |
Canasa Pediatric Safety Review |
09/01/2020 |
Contegra Pulmonary Valved Conduit (HDE) |
Contegra Pulmonary Valved Conduit Executive Summary |
09/01/2020 |
Descovy® (emtricitabine and tenofovir alafenamide) |
Descovy® Pediatric Safety Review |
09/01/2020 |
Elana Surgical Kit (HDE) |
Elana Surgical Kit Executive Summary |
09/01/2020 |
Enterra Therapy System (HDE) |
Enterra Therapy System Executive Summary |
09/01/2020 |
Flucelvax (influenza vaccine) |
Flucelvax Safety and Utilization Review |
09/01/2020 |
Flucelvax Quadrivalent (influenza vaccine) |
Flucelvax Quadrivalent Safety and Utilization Review |
09/01/2020 |
FluLaval (influenza vaccine) |
FluLaval Safety and Utilization Review |
09/01/2020 |
FluLaval Quadrivalent (influenza vaccine) |
FluLaval Quadrivalent Safety and Utilization Review |
09/01/2020 |
Genvoya® (elvitegravir, cobicistat, emtricitabine, and tenofovir |
Genvoya® Pediatric Safety Review |
09/01/2020 |
Hiberix [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] |
Hiberix Safety and Utilization Review |
09/01/2020 |
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted |
Influenza A (H5N1) Virus Monovalent Vaccine Safety and Utilization Review |
09/01/2020 |
Lumify (brimonidine tartrate) OTC |
Lumify Pediatric Safety Review |
09/01/2020 |
Luzu (luliconazole) cream, 1% |
Luzu Pediatric Safety Review |
09/01/2020 |
Pleximmune™ in-vitro diagnostic test (HDE) |
Pleximmune™ in-vitro diagnostic test Executive Summary |
09/01/2020 |
PulseRider Aneurysm Neck Reconstruction Device (HDE) |
PulseRider Aneurysm Neck Reconstruction Device Executive Summary |
09/01/2020 |
Sensipar (cinacalcet) |
Sensipar Pediatric Safety Review |
09/01/2020 |
Triumeq (abacavir, dolutegravir, and lamivudine) |
Triumeq Pediatric Safety Review |
09/01/2020 |
Xepi (ozenoxacin) |
Xepi Pediatric Safety Review |
09/01/2020 |
Aptiom (eslicarbazepine acetate) |
Aptiom Pediatric Postmarketing Pharmacovigilance Review |
04/26/2021 |
Cotempla XR-ODT (methylphenidate extended release orally disintegrating tablets) |
Cotempla Pediatric Postmarketing Pharmacovigilance Review |
04/26/2021 |
Cuvitru, Immune Globulin Subcutaneous (Human) (IGSC), 20% Solution |
Cuvitru Safety and Utilization Review |
04/26/2021 |
Epicel (cultured epidermal autografts) |
Epicel Safety Update |
04/26/2021 |
JIVI (Antihemophilic Factor (Recombinant), PEGylated-aucl) |
JIVI Safety and Utilization Review |
04/26/2021 |
Liposorber® LA-15 System |
Liposorber® LA-15 System Executive Summary |
04/26/2021 |
Medtronic Activa® Dystonia Therapy (HDE) |
Medtronic Activa® Dystonia Therapy Executive Summary |
04/26/2021 |
Minimally Invasive Deformity Correction (MID-C) System |
Minimally Invasive Deformity Correction (MID-C) System Executive Summary |
04/26/2021 |
Pegasys (peginterferon alpha-2a) |
Pegasys Pediatric Postmarketing Pharmacovigiliance Review |
04/26/2021 |
REBINYN (nonacog beta pegol (N9-GP)) |
REBINYN Safety and Utilization Review |
04/26/2021 |
The Tether™ – Vertebral Body Tethering System |
The Tether™ – Vertebral Body Tethering System Executive Summary |
04/26/2021 |
Vimovo (naproxen/esomeprazole magnesium) |
Vimovo Pediatric Postmarketing Pharmacovigilance Review |
04/26/2021 |
Cialis (tadalafil) |
Cialis Pediatric Postmarketing Pharmacovigilance Review |
09/03/2021 |
Elana Surgical Kit (HDE) |
Elana Surgical Kit Executive Summary |
09/03/2021 |
Emend (fosaprepitant dimeglumine) |
Emend Pediatric Postmarketing Pharmacovigilance Review |
09/03/2021 |
Enbrel (etanercept), Erelzi (etanercept-szzs), Eticovo (etanercept-ykro) |
Enbrel Pediatric Postmarketing Pharmacovigilance Review |
09/03/2021 |
Enterra Therapy System (HDE) |
Enterra Therapy System Executive Summary |
09/03/2021 |
Fasenra (benralizumab) |
Fasenra Pediatric Postmarketing Pharmacovigilance Review |
09/03/2021 |
Intelence (etravirine) |
Intelence Pediatric Postmarketing Pharmacovigilance Review |
09/03/2021 |
Medtronic Contegra Pulmonary Valved Conduit (HDE) |
Medtronic Contegra Pulmonary Valved Conduit Executive Summary |
09/03/2021 |
Pleximmune™ in-vitro diagnostic test (HDE) |
Pleximmune Executive Summary |
09/03/2021 |
PulseRider Aneurysm Neck Reconstruction Device (HDE) |
PulseRider Aneurysm Neck Reconstruction Device Executive Summary |
09/03/2021 |
RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent) |
Rotateq Safety and Utilization Review |
09/03/2021 |
Rubber Panel T.R.U.E. TEST (Rubber Panel Thin-Layer Rapid Use Epicutaneous Patch Test) |
Rubber Panel T.R.U.E. TEST Safety and Utilization Review |
09/03/2021 |
T.R.U.E. TEST (Thin-Layer Rapid Use Epicutaneous Patch Test) |
T.R.U.E. TEST Safety and Utilization Review |
09/03/2021 |
Tekturna (aliskiren hemifumarate) |
Tekturna Pediatric Postmarketing Pharmacovigilance Review |
09/03/2021 |
Viread (tenofovir disoproxil fumarate) |
Viread Pediatric Postmarketing Pharmacovigilance Review |
09/03/2021 |
Xofluza (baloxavir marboxil) |
Xofluza Pediatric Postmarketing Pharmacovigilance Review |
09/03/2021 |
Actemra (tocilizumab) |
Actemra Pediatric Postmarketing Pharmacoviligalance Review |
4/19/2022 |
Activa Dystonia Therapy (none) |
Medtronic Activa Neurostimulator for Dystonia Treatment Executive Summary |
4/25/2022 |
Amitiza (lubiprostone) |
Amitiza Pediatric Postmarketing Pharmacovigilance Review |
4/25/2022 |
Epicel (cultured epidermal autografts) |
Epicel (cultured epidermal autografts) Safety Update Memorandum |
4/25/2022 |
ESPEROCT (Antihemophilic Factor (Recombinant), GlycoPEGylated-exei) |
ESPEROCT (Antihemophilic Factor (Recombinant), GlycoPEGylated-exei) Safety Update Memorandum |
4/25/2022 |
Liposorber LA-15 System (none) |
Liposorber LA-15 System Executive Summary |
4/25/2022 |
Mavyret (glecaprevir/pibrentasvir) |
Mavyret (glecaprevir/pibrentasvir) Pediatric Postmarketing Pharmacovigilance Review |
4/25/2022 |
Minimally Invasive Deformity Correction (MID-C) System (none) |
Minimally Invasive Deformity Correction (MID-C) System (none) Executive Summary |
4/25/2022 |
PANZYGA (Immune Globulin Intravenous, human-ifas) |
PANZYGA (Immune Globulin Intravenous, human-ifas) Safety Update Memorandum |
4/25/2022 |
Pristiq (desvenlafaxine) |
Pristiq (desvenlafaxine) Pediatric Postmarketing Pharmacovigilance Review |
4/25/2022 |
Slynd (drospirenone) |
Slynd (drospirenone) Pediatric Postmarketing Pharmacovigilance Review |
4/25/2022 |
The Tether - Vertebral Body Tethering System (none) |
The Tether - Vertebral Body Tethering System (none) Executive Summary |
4/25/2022 |
Xembify (immune globulin subcutaneous, human – klhw) |
Xembify (immune globulin subcutaneous, human – klhw) Safety Update Memorandum |
4/25/2022 |
Xolair (omalizumab) |
Xolair (omalizumab) Pediatric Postmarketing Pharmacovigilance Review |
4/25/2022 |
Asceniv (Immune Globulin Intravenous (Human), 10% Liquid) |
Asceniv (Immune Globulin Intravenous (Human), 10% Liquid) Safety Update Memorandum |
8/18/2022 |
Benlysta (belimumab) |
Benlysta (belimumab) Pediatric Postmarketing Pharmacovigilance Review |
8/18/2022 |
Contegra (none) |
Medtronic Contegra Pulmonary Valved Circuit Models 200 and 200s Executive Summary |
8/18/2022 |
Enterra Gastric Electrical Stimulator (none) |
Enterra Therapy System Executive Summary |
8/18/2022 |
FIBRYGA (Fibrinogen (Human)) |
FIBRYGA (Fibrinogen (Human)) Safety Update Memorandum |
8/18/2022 |
Flourish Pediatric Esophageal Atresia Device (none) |
Flourish Pediatric Esophageal Atresia Device Executive Summary |
8/18/2022 |
Pleximmune (none) |
Pleximmune Executive Summary |
8/18/2022 |
PulseRider Aneurysm Neck Reconstruction Device (none) |
PulseRider Aneurysm Neck Reconstruction Device Executive Summary |
8/18/2022 |
Sonalleve MR-HIFU (None) |
Sonalleve MR-HIFU Executive Summary |
8/18/2022 |
Vfend (voriconazole) |
Vfend (voriconazole) Pediatric Postmarketing Pharmacovigilance Review |
8/18/2022 |
Wilate (von Willebrand Factor/Coagulation Factor VIII Complex (Human)) |
Wilate (von Willebrand Factor/Coagulation Factor VIII Complex (Human)) Safety Update Memorandum |
8/18/2022 |
Mavyret (glecaprevir/pibrentasvir) |
Mavyret (glecaprevir/pibrentasvir) Pediatric Postmarketing Pharmacovigilance Review |
9/22/2022 |
Actemra (tocilizumab) |
Actemra (tocilizumab) Actemra Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Actemra (tocilizumab) |
Actemra (tocilizumab) Actemra Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Activa Dystonia Therapy (none) |
Activa Dystonia Therapy Executive Summary |
4/19/2023 |
AFLURIA; AFLURIA QUADRIVALENT (Influenza Vaccine) |
AFLURIA; AFLURIA QUADRIVALENT (Influenza Vaccine) Safety Update Memorandum |
4/19/2023 |
Altreno lotion (tretinoin) |
Altreno lotion (tretinoin) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Arnuity Ellipta (fluticasone furoate) |
Arnuity Ellipta (fluticasone furoate) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Astagraf XL (tacrolimus) |
Astagraf XL (tacrolimus) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Avycaz (ceftazidime/avibactam) |
Avycaz (ceftazidime/avibactam) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Botox (onabotulinumtoxinA) |
Botox (onabotulinumtoxinA) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Botox (onabotulinumtoxinA) |
Botox (onabotulinumtoxinA) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Botox (onabotulinumtoxinA) |
Botox (onabotulinumtoxinA) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Botox injection (onabotulinumtoxinA) |
Botox injection (onabotulinumtoxinA) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Botox injection (onabotulinumtoxinA) |
Botox injection (onabotulinumtoxinA) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Breo Ellipta (fluticasone furoate/vilanterol) |
Breo Ellipta (fluticasone furoate/vilanterol) Safety Update Memorandum |
4/19/2023 |
Briviact (brivaracetam) |
Briviact (brivaracetam) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Briviact tablets, solution, and injection (brivaracetam) |
Briviact tablets, solution, and injection (brivaracetam) Safety Update Memorandum |
4/19/2023 |
Clenpiq (sodium picosulfate/magnesium oxide/anhydrous citric acid) |
Clenpiq (sodium picosulfate/magnesium oxide/anhydrous citric acid) Postmarketing Pharmacovigilance Review |
4/19/2023 |
Corlanor Oral Solution (ivabradine) |
Corlanor Oral Solution Executive Summary |
4/19/2023 |
Cystadrops ophthalmic solution (cysteamine) |
Cystadrops ophthalmic solution (cysteamine) Safety Update Memorandum |
4/19/2023 |
Descovy (emtricitabine/tenofovir alafenamide) |
Descovy (emtricitabine/tenofovir alafenamide) Safety Update Memorandum |
4/19/2023 |
Dysport (abobotulinumtoxinA) |
Dysport (abobotulinumtoxinA) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Effient (prasugrel) |
Effient (prasugrel) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Epicel (cultured epidermal autografts) |
Epicel (cultured epidermal autografts) Safety Update Memorandum |
4/19/2023 |
Fluarix Quadrivalent (Influenza Vaccine) |
Fluarix Quadrivalent (Influenza Vaccine) Safety Update Memorandum |
4/19/2023 |
Fycompa (perampanel) |
Fycompa (perampanel) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Granix injection (tbo-filgrastim) |
Granix injection (tbo-filgrastim) Safety Update Memorandum |
4/19/2023 |
Harvoni (ledipasvir/sofosbuvir) |
Harvoni (ledipasvir/sofosbuvir) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Jornay PM (methylphenidate) |
Jornay PM (methylphenidate) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Katerzia oral suspension (amlodipine benzoate) |
Katerzia oral suspension (amlodipine benzoate) Safety Update Memorandum |
4/19/2023 |
Kerydin topical solution (tavaborole) |
Kerydin topical solution (tavaborole) Safety Update Memorandum |
4/19/2023 |
Liposorber LA-15 System (none) |
Liposorber LA-15 System Executive Summary |
4/19/2023 |
Livalo (pitavastatin) |
Livalo (pitavastatin) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Lyrica (pregabalin) |
Lyrica (pregabalin) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Minimally Invasive Deformity Correction (MID-C) System (none) |
Minimally Invasive Deformity Correction (MID-C) System Executive Summary |
4/19/2023 |
Prepopik for oral solution (sodium picosulfate/magnesium oxide/anhydrous citric acid) |
Prepopik for oral solution (sodium picosulfate/magnesium oxide/anhydrous citric acid) Executive Summary |
4/19/2023 |
Procysbi (cysteamine bitartrate) |
Procysbi (cysteamine bitartrate) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
PulseRider Aneurysm Neck Reconstruction Device (none) |
PulseRider Aneurysm Neck Reconstruction Device Safety Update Memorandum |
4/19/2023 |
Qbrexza cloth (glycopyrronium) |
Qbrexza cloth (glycopyrronium) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Seysara (sarecycline) |
Seysara (sarecycline) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Sovaldi (sofosbuvir) |
Sovaldi (sofosbuvir) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
The Tether - Vertebral Body Tethering System (none) |
The Tether - Vertebral Body Tethering System Executive Summary |
4/19/2023 |
Twyneo cream (tretinoin/benzoyl peroxide) |
Twyneo cream (tretinoin/benzoyl peroxide) Safety Update Memorandum |
4/19/2023 |
Winlevi cream (clascoterone) |
Winlevi cream (clascoterone) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Xeomin injection (incobotulinumtoxinA) |
Xeomin injection (incobotulinumtoxinA) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Zovirax injection (acyclovir) |
Zovirax injection (acyclovir) Pediatric Postmarketing Pharmacovigilance Review |
4/19/2023 |
Dysport (abobotulinumtoxinA) |
Dysport (abobotulinumtoxinA) Pediatric Postmarketing Pharmacovigilance Review |
6/19/2023 |
Annovera (segesterone acetate/ethinyl estradiol ) |
Annovera (segesterone acetate/ethinyl estradiol ) Safety Update Memorandum |
10/26/2023 |
Aptensio XR (methylphenidate hydrochloride) |
Aptensio XR (methylphenidate hydrochloride) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) |
Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Safety Update Memorandum |
10/26/2023 |
Contegra (none) |
Contegra Pediatric Executive Summary |
10/26/2023 |
Dificid (fidaxomicin) |
Dificid (fidaxomicin) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Enterra Gastric Electrical Stimulator (none) |
Enterra Gastric Electrical Stimulator Executive Summary |
10/26/2023 |
Epclusa (sofosbuvir/velpatasvir) |
Epclusa (sofosbuvir/velpatasvir) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Epclusa oral pellets (sofosbuvir/velpatasvir) |
Epclusa oral pellets (sofosbuvir/velpatasvir) Safety Update Memorandum |
10/26/2023 |
Flector Topical System (diclofenac epolamine) |
Flector Topical System Executive Summary |
10/26/2023 |
Flourish Pediatric Esophageal Atresia Device (none) |
Flourish Pediatric Esophageal Atresia Device Executive Summary |
10/26/2023 |
Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) |
Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) Safety Update Memorandum |
10/26/2023 |
Jevtana (cabazitaxel) |
Jevtana (cabazitaxel) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Nucala (mepolizumab) |
Nucala (mepolizumab) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) |
ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) Executive Summary |
10/26/2023 |
Otiprio (ciprofloxacin) |
Otiprio (ciprofloxacin) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Phexxi vaginal gel (lactic acid/citric acid/potassium bitartrate) |
Phexxi vaginal gel (lactic acid/citric acid/potassium bitartrate) Executive Summary |
10/26/2023 |
Pleximmune (none) |
Pleximmune (none) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Promacta (eltrombopag) |
Promacta (eltrombopag) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
PulseRider Aneurysm Neck Reconstruction Device (none) |
PulseRider Aneurysm Neck Reconstruction Device Executive Summary |
10/26/2023 |
Saxenda injection (liraglutide) |
Saxenda injection (liraglutide) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Sonalleve MR-HIFU (None) |
Sonalleve MR-HIFU Executive Summary |
10/26/2023 |
Sorilux (calcipotriene) |
Sorilux (calcipotriene) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Tivicay PD tablets for oral suspension (dolutegravir) |
Tivicay PD tablets for oral suspension (dolutegravir) Postmarketing Pharmacovigilance Review |
10/26/2023 |
Tivicay tablets (dolutegravir) |
Tivicay tablets (dolutegravir) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B [Recombinant] Vaccine) |
VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B [Recombinant] Vaccine) Safety Update Memorandum |
10/26/2023 |
Victoza (liraglutide) |
Victoza (liraglutide) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Vimpat (lacosamide) |
Vimpat (lacosamide) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Yondelis injection (trabectedin) |
Yondelis injection (trabectedin) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Zerviate (cetirizine) |
Zerviate (cetirizine) Pediatric Postmarketing Pharmacovigilance Review |
10/26/2023 |
Aczone Gel (dapsone) |
Aczone Gel (dapsone) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Adhansia XR (methylphenidate hydrochloride) |
Adhansia XR (methylphenidate hydrochloride) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Aklief (trifarotene) |
Aklief (trifarotene) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Ampicillin Injection (ampicillin) |
Ampicillin Injection (ampicillin) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Amzeeq (minocycline) |
Amzeeq (minocycline) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Arazlo (tazarotene) |
Arazlo (tazarotene) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Asmanex HFA (mometasone furoate) |
Asmanex HFA (mometasone furoate) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Baqsimi nasal powder (glucagon) |
Baqsimi nasal powder (glucagon) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Ciloxan ophthalmic solution (ciprofloxacin) |
Ciloxan ophthalmic solution (ciprofloxacin) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Conjupri (levamlodipine) |
Conjupri (levamlodipine) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Doptelet tablet (avatrombopag) |
Doptelet tablet (avatrombopag) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Dulera Inhalation Aerosol (formoterol fumarate/mometasone furoate) |
Dulera Inhalation Aerosol Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Dutrebis (lamivudine/raltegravir) |
Dutrebis (lamivudine/raltegravir) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Enstilar Foam (calcipotriene/betamethasone dipropionate) |
Enstilar Foam (calcipotriene/betamethasone dipropionate) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Gvoke (glucagon) |
Gvoke (glucagon) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Jublia topical solution (efinaconazole) |
Jublia topical solution (efinaconazole) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Nuvessa (metronidazole) |
Nuvessa (metronidazole) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Prezcobix tablets (darunavir/cobicistat) |
Prezcobix tablets (darunavir/cobicistat)Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Primatene Mist (epinephrine) |
Primatene Mist (epinephrine) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Quzyttir (cetirizine hydrochloride) |
Quzyttir (cetirizine hydrochloride) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Sivextro tablet (tedizolid phosphate) |
Sivextro tablet (tedizolid phosphate) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Spy Agent Green (Indocyanine green) |
Spy Agent Green (Indocyanine green) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Symtuza tablets (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) |
Symtuza tablets (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Taclonex (calcipotriene/betamethasone dipropionate) |
Taclonex (calcipotriene/betamethasone dipropionate) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Taltz injection (ixekizumab) |
Taltz injection (ixekizumab) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Truvada (emtricitabine/tenofovir disoproxil fumarate) |
Truvada (emtricitabine/tenofovir disoproxil fumarate) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Vectical ointment (calcitriol) |
Vectical ointment (calcitriol) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
VESIcare LS oral suspension (solifenacin succinate) |
VESIcare LS oral suspension (solifenacin succinate) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Welchol (colesevelam hydrochloride) |
Welchol (colesevelam hydrochloride) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Welchol Chewable Bar (colesevelam HCl) |
Welchol Chewable Bar (colesevelam HCl) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |
Xtoro (finafloxacin) |
Xtoro (finafloxacin) Pediatric Postmarketing Pharmacovigilance Review |
12/21/2023 |